Literature DB >> 28084326

Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test.

Eric M Reiman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28084326     DOI： 10.1038/nrneurol.2017.1

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  7 in total

1.  Alzheimer's disease: Attack on amyloid-β protein.

Authors:  Eric M Reiman
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

2.  The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

Authors:  Jeff Sevigny; Ping Chiao; Thierry Bussière; Paul H Weinreb; Leslie Williams; Marcel Maier; Robert Dunstan; Stephen Salloway; Tianle Chen; Yan Ling; John O'Gorman; Fang Qian; Mahin Arastu; Mingwei Li; Sowmya Chollate; Melanie S Brennan; Omar Quintero-Monzon; Robert H Scannevin; H Moore Arnold; Thomas Engber; Kenneth Rhodes; James Ferrero; Yaming Hang; Alvydas Mikulskis; Jan Grimm; Christoph Hock; Roger M Nitsch; Alfred Sandrock
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

3.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

Review 4.  CAP--advancing the evaluation of preclinical Alzheimer disease treatments.

Authors:  Eric M Reiman; Jessica B Langbaum; Pierre N Tariot; Francisco Lopera; Randall J Bateman; John C Morris; Reisa A Sperling; Paul S Aisen; Allen D Roses; Kathleen A Welsh-Bohmer; Maria C Carrillo; Stacie Weninger
Journal:  Nat Rev Neurol       Date:  2015-09-29       Impact factor: 42.937

5.  Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Authors:  Mehtap Bacioglu; Luis F Maia; Oliver Preische; Juliane Schelle; Anja Apel; Stephan A Kaeser; Manuel Schweighauser; Timo Eninger; Marius Lambert; Andrea Pilotto; Derya R Shimshek; Ulf Neumann; Philipp J Kahle; Matthias Staufenbiel; Manuela Neumann; Walter Maetzler; Jens Kuhle; Mathias Jucker
Journal:  Neuron       Date:  2016-06-09       Impact factor: 17.173

6.  Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.

Authors:  Tobias Bittner; Henrik Zetterberg; Charlotte E Teunissen; Richard E Ostlund; Michael Militello; Ulf Andreasson; Isabelle Hubeek; David Gibson; David C Chu; Udo Eichenlaub; Peter Heiss; Uwe Kobold; Andreas Leinenbach; Kairat Madin; Ekaterina Manuilova; Christina Rabe; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2015-11-10       Impact factor: 21.566

Review 7.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137
  7 in total
  6 in total

Review 1.  How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database.

Authors:  Stavros I Dimitriadis; Dimitris Liparas
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

2.  Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.

Authors:  Adam M Staffaroni; Yann Cobigo; Sheng-Yang M Goh; John Kornak; Lynn Bajorek; Kevin Chiang; Brian Appleby; Jessica Bove; Yvette Bordelon; Patrick Brannelly; Danielle Brushaber; Christina Caso; Giovanni Coppola; Reilly Dever; Christina Dheel; Bradford C Dickerson; Susan Dickinson; Sophia Dominguez; Kimiko Domoto-Reilly; Kelly Faber; Jessica Ferrall; Julie A Fields; Ann Fishman; Jamie Fong; Tatiana Foroud; Leah K Forsberg; Ralitza Gavrilova; Debra Gearhart; Behnaz Ghazanfari; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Ian Grant; Murray Grossman; Dana Haley; Hilary W Heuer; Ging-Yuek Hsiung; Edward D Huey; David J Irwin; David T Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; Daniel I Kaufer; Diana R Kerwin; David S Knopman; Ruth Kraft; Joel H Kramer; Walter K Kremers; Walter A Kukull; Irene Litvan; Peter A Ljubenkov; Diane Lucente; Codrin Lungu; Ian R Mackenzie; Miranda Maldonado; Masood Manoochehri; Scott M McGinnis; Emily McKinley; Mario F Mendez; Bruce L Miller; Namita Multani; Chiadi Onyike; Jaya Padmanabhan; Alex Pantelyat; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine P Rankin; Katya Rascovsky; Erik D Roberson; Emily Rogalski; Pheth Sengdy; Leslie M Shaw; Jeremy Syrjanen; M Carmela Tartaglia; Nadine Tatton; Joanne Taylor; Arthur Toga; John Q Trojanowski; Sandra Weintraub; Ping Wang; Bonnie Wong; Zbigniew Wszolek; Adam L Boxer; Brad F Boeve; Howard J Rosen
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

3.  Task-dependent learning and memory deficits in the TgF344-AD rat model of Alzheimer's disease: three key timepoints through middle-age in females.

Authors:  Victoria E Bernaud; Haidyn L Bulen; Veronica L Peña; Stephanie V Koebele; Steven N Northup-Smith; Alma A Manzo; Maria Valenzuela Sanchez; Zorana Opachich; Ashley M Ruhland; Heather A Bimonte-Nelson
Journal:  Sci Rep       Date:  2022-08-26       Impact factor: 4.996

Review 4.  Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids.

Authors:  Magdalena Korecka; Leslie M Shaw
Journal:  J Neurochem       Date:  2021-08-25       Impact factor: 5.546

Review 5.  Current state of Alzheimer's fluid biomarkers.

Authors:  José Luis Molinuevo; Scott Ayton; Richard Batrla; Martin M Bednar; Tobias Bittner; Jeffrey Cummings; Anne M Fagan; Harald Hampel; Michelle M Mielke; Alvydas Mikulskis; Sid O'Bryant; Philip Scheltens; Jeffrey Sevigny; Leslie M Shaw; Holly D Soares; Gary Tong; John Q Trojanowski; Henrik Zetterberg; Kaj Blennow
Journal:  Acta Neuropathol       Date:  2018-11-28       Impact factor: 17.088

6.  Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.

Authors:  Valentina Ghisays; Dhruman D Goradia; Hillary Protas; Robert J Bauer; Vivek Devadas; Pierre N Tariot; Val J Lowe; David S Knopman; Ronald C Petersen; Clifford R Jack; Richard J Caselli; Yi Su; Kewei Chen; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2020-01-16       Impact factor: 21.566
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.